• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.关于心房颤动择期电复律后窦性心律维持相关因素的综述。
Clin Cardiol. 2018 Jun;41(6):862-870. doi: 10.1002/clc.22931. Epub 2018 Jun 7.
2
Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.电复律转复心房颤动后窦律维持的预测因素：Flec-SL 试验数据集的数据挖掘项目结果。
Europace. 2017 Jun 1;19(6):921-928. doi: 10.1093/europace/euw144.
3
The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.从持续性心房颤动管理的随机研究角度看RACE研究
Card Electrophysiol Rev. 2003 Jun;7(2):118-21. doi: 10.1023/a:1027439430017.
4
Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study.当代心房颤动的真实生活心脏复律：多国RHYTHM-AF研究结果
Int J Cardiol. 2014 Apr 1;172(3):588-94. doi: 10.1016/j.ijcard.2014.01.099. Epub 2014 Jan 25.
5
Systematic analysis of ECG predictors of sinus rhythm maintenance after electrical cardioversion for persistent atrial fibrillation.持续性心房颤动电复律后窦性心律维持的心电图预测因素的系统分析。
Heart Rhythm. 2016 May;13(5):1020-1027. doi: 10.1016/j.hrthm.2016.01.004. Epub 2016 Jan 8.
6
The mechanical fibrillation pattern of the atrial myocardium is associated with acute and long-term success of electrical cardioversion in patients with persistent atrial fibrillation.心房心肌的机械性颤动模式与持续性心房颤动患者电复律的短期和长期成功率相关。
Heart Rhythm. 2014 Sep;11(9):1514-21. doi: 10.1016/j.hrthm.2014.04.029. Epub 2014 Apr 21.
7
CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.CHA2DS2-VASc评分在预测电复律或药物复律后早期房颤复发中的应用
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):636-41. doi: 10.2459/JCM.0000000000000139.
8
Short-term amiodarone therapy after reversion of persistent atrial fibrillation reduces recurrences at 18 months.持续性心房颤动复律后短期应用胺碘酮治疗可降低18个月时的复发率。
Cardiol J. 2014;21(4):397-404. doi: 10.5603/CJ.a2013.0152. Epub 2013 Dec 2.
9
A shock-free approach for ambulatory cardioversion in atrial fibrillation.无电击方案用于房颤患者的门诊电复律。
Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H245-H247. doi: 10.1152/ajpheart.00847.2020. Epub 2020 Dec 4.
10
Atrial fibrillation: choosing an antiarrhythmic drug.心房颤动：选择一种抗心律失常药物。
Curr Cardiol Rep. 2006 Sep;8(5):370-6. doi: 10.1007/s11886-006-0077-z.

引用本文的文献

1
MR-proANP, sST2, BNP and sinus rhythm maintenance 1 year after electrical cardioversion for atrial fibrillation.房颤电复律后1年的中段心房利钠肽前体、可溶性生长刺激表达基因2蛋白、脑钠肽与窦性心律维持情况
BMC Cardiovasc Disord. 2025 Aug 29;25(1):640. doi: 10.1186/s12872-025-05052-5.
2
Left atrial volume index: A predictor of atrial fibrillation recurrence following direct current cardioversion - A systematic review and meta-analysis.左心房容积指数：直流电复律后房颤复发的预测指标——一项系统评价和荟萃分析
Int J Cardiol Heart Vasc. 2024 Feb 23;51:101364. doi: 10.1016/j.ijcha.2024.101364. eCollection 2024 Apr.
3
Atrial fibrillation: better symptom control with rate and rhythm management.心房颤动：通过心率和节律管理实现更好的症状控制。
Lancet Reg Health Eur. 2024 Feb 1;37:100801. doi: 10.1016/j.lanepe.2023.100801. eCollection 2024 Feb.
4
Implementation of a screening and management pathway for chronic obstructive pulmonary disease in patients with atrial fibrillation.实施慢性阻塞性肺疾病患者伴心房颤动的筛查和管理路径。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad193.
5
Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion.阵发性或持续性心房颤动患者经体外直流电复律后心房颤动复发的生物标志物
Biomedicines. 2023 May 16;11(5):1452. doi: 10.3390/biomedicines11051452.
6
Electrical cardioversion intervention in a patient with heat stroke accompanied by rapid atrial fibrillation: A case report and literature review.中暑伴快速心房颤动患者的电复律干预：一例报告及文献复习
Heliyon. 2023 Apr 20;9(5):e15636. doi: 10.1016/j.heliyon.2023.e15636. eCollection 2023 May.
7
Non-coding RNA and arrhythmias: expression, function, and molecular mechanism.非编码 RNA 与心律失常：表达、功能与分子机制。
Europace. 2023 Apr 15;25(4):1296-1308. doi: 10.1093/europace/euad047.
8
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation.早期症状性心房颤动自发转复的发生率及决定因素。
Medicina (Kaunas). 2022 Oct 24;58(11):1513. doi: 10.3390/medicina58111513.
9
Mid-Diastolic Events (L Events): A Critical Review.舒张中期事件（L事件）：一项批判性综述。
J Clin Med. 2021 Nov 30;10(23):5654. doi: 10.3390/jcm10235654.
10
Review of the 2020 ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation-What Has Changed and How Does This Affect Daily Practice.2020年欧洲心脏病学会心房颤动诊断和管理指南解读——有哪些变化以及如何影响日常实践
J Clin Med. 2021 Aug 30;10(17):3922. doi: 10.3390/jcm10173922.

本文引用的文献

1
Outcomes of Direct Current Cardioversion in Adults With Congenital Heart Disease.成人先天性心脏病患者直流电复律的治疗结果
Am J Cardiol. 2017 May 1;119(9):1468-1472. doi: 10.1016/j.amjcard.2017.01.018. Epub 2017 Feb 9.
2
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.维纳卡兰相对于伊布利特在急诊室新发生心房颤动患者中更有助于恢复窦性节律：一项随机对照试验。
Europace. 2017 Feb 1;19(2):233-240. doi: 10.1093/europace/euw052.
3
Predicting Unsuccessful Electrical Cardioversion for Acute Atrial Fibrillation (from the AF-CVS Score).预测急性房颤电复律失败（源自AF-CVS评分）
Am J Cardiol. 2017 Mar 1;119(5):749-752. doi: 10.1016/j.amjcard.2016.11.026. Epub 2016 Dec 2.
4
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动管理指南。
Eur J Cardiothorac Surg. 2016 Nov;50(5):e1-e88. doi: 10.1093/ejcts/ezw313. Epub 2016 Sep 23.
5
Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.醛固酮受体拮抗剂与心房颤动：一项荟萃分析。
Europace. 2016 May;18(5):672-8. doi: 10.1093/europace/euv366. Epub 2015 Dec 23.
6
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.心房颤动复律后用于维持窦性心律的抗心律失常药物。
Cochrane Database Syst Rev. 2015 Mar 28(3):CD005049. doi: 10.1002/14651858.CD005049.pub4.
7
Role of inflammation in atrial fibrillation pathophysiology and management.炎症在心房颤动病理生理学及管理中的作用。
Circ J. 2015;79(3):495-502. doi: 10.1253/circj.CJ-15-0138. Epub 2015 Feb 16.
8
Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study.我们能否预测急性房颤电复律的失败？FinCV研究。
Pacing Clin Electrophysiol. 2015 Mar;38(3):368-75. doi: 10.1111/pace.12561. Epub 2014 Dec 23.
9
Predictors of long-term maintenance of normal sinus rhythm after successful electrical cardioversion.成功电复律后正常窦性心律长期维持的预测因素。
Clin Cardiol. 2014 Jun;37(6):381-5. doi: 10.1002/clc.22276. Epub 2014 Apr 3.
10
Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.肾素-血管紧张素系统抑制剂预防心房颤动复发的Meta 分析。
Int J Clin Pract. 2013 Jun;67(6):536-43. doi: 10.1111/ijcp.12063. Epub 2013 Apr 5.

关于心房颤动择期电复律后窦性心律维持相关因素的综述。

A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.

作者信息

Ecker Veronika, Knoery Charles, Rushworth Gordon, Rudd Ian, Ortner Astrid, Begley David, Leslie Stephen J

机构信息

Institute for Pharmaceutical Sciences, Karl-Franzens-Universität, Graz, Austria.

NHS Highland, Assynt House, Beechwood Park, Inverness, UK.

出版信息

Clin Cardiol. 2018 Jun;41(6):862-870. doi: 10.1002/clc.22931. Epub 2018 Jun 7.

DOI:10.1002/clc.22931
PMID:29878481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6489932/
Abstract

Atrial fibrillation is the most common heart-rhythm disorder, affecting about 1.5% to 2% of the population with an increased risk of mortality and morbidity due to stroke, thromboembolism, and heart failure. If the conversion back to sinus rhythm does not happen spontaneously, pharmacological or electrical cardioversion (ECV) is the next available treatment options for some patients. However, the long-term success following ECV is variable. This review describes the factors that are associated with maintenance of sinus rhythm following ECV and proposes a clinical strategy based on the available evidence.

摘要

心房颤动是最常见的心律失常，影响约1.5%至2%的人口，因中风、血栓栓塞和心力衰竭导致死亡率和发病率增加。如果不能自发恢复窦性心律，药物或电复律（ECV）是一些患者的下一个可用治疗选择。然而，ECV后的长期成功率各不相同。本综述描述了与ECV后窦性心律维持相关的因素，并根据现有证据提出了一种临床策略。